As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves ...

Its weight-loss drug policy would fall to Trump's pick for health secretary, Robert F Kennedy Jr, and Mehmet Oz, Trump's ...